(Q43845589)

27 November 2017

title

Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients (English)

1 reference

27 November 2017

Swift RH

1

1 reference

27 November 2017

Harrigan EP

2

1 reference

27 November 2017

Cappelleri JC

3

1 reference

27 November 2017

Kramer D

4

1 reference

27 November 2017

Chandler LP

5

1 reference

27 November 2017

publication date

1 March 2002

1 reference

Journal of Psychiatric Research

27 November 2017

published in

1 reference

27 November 2017

volume

36

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

87-95

1 reference

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

A randomized controlled double blind study of zuclopenthixol acetate compared to haloperidol in acute psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Development of a scale for assessment of agitation following traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

The Caretaker Obstreperous-Behavior Rating Assessment (COBRA) Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Pyramidical model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

A user-friendly instrument for rating agitation in dementia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Intraclass correlations: uses in assessing rater reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

A new scale for assessing behavioral agitation in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

The Overt Aggression Scale for the objective rating of verbal and physical aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900052-8

10.1016/S0022-3956(01)00052-8

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference